MedPath

MAR-LACOSAMIDE

MAR-LACOSAMIDE

Dormant
DIN Number

02487802

Drug Class

Human

Market Date

Oct 4, 2019

Company
HC

marcan pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02487802
AIG Number0152810001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N03AX18 LACOSAMIDE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

LACOSAMIDEActive
Strength: 50 MG
Monograph: LACOSAMIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.